-
1
المؤلفون: Lars Ny, Lisa M. Nilsson, Vasu R. Sah, Jonas Nilsson, Joakim Karlsson, Henrik Jespersen, Mattias F. Lindberg
المصدر: Melanoma research. 32(4)
مصطلحات موضوعية: Cancer Research, Skin Neoplasms, medicine.drug_class, medicine.medical_treatment, Melanoma, Experimental, Dermatology, B7-H1 Antigen, Targeted therapy, Epigenesis, Genetic, chemistry.chemical_compound, Mice, medicine, Animals, Epigenetics, neoplasms, Melanoma, Entinostat, business.industry, Therapeutic effect, Histone deacetylase inhibitor, Immunotherapy, medicine.disease, Oncology, chemistry, Cancer research, business, Epigenetic therapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163c4bbe494fda83657bdc9bc2c8d481Test
https://pubmed.ncbi.nlm.nih.gov/34753889Test -
2
المؤلفون: Charlotta All-Eriksson, Stefan Filges, Ingrid Ljuslinder, Lars Ny, Hildur Helgadottir, Lisa M. Nilsson, Henrik Jespersen, Vasu R. Sah, Max Levin, Gustav J. Ullenhag, Jonas Nilsson, Samuel Alsén, Joakim Karlsson, Bengt Andersson, Anders Ståhlberg, Roger Olofsson Bagge, Ulrika Stierner, Ana Carneiro
المصدر: Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)مصطلحات موضوعية: Uveal Neoplasms, Oncology, medicine.medical_specialty, Pyridines, Science, medicine.medical_treatment, General Physics and Astronomy, Phases of clinical research, Cancer immunotherapy, Pembrolizumab, Antibodies, Monoclonal, Humanized, Article, Phase II trials, General Biochemistry, Genetics and Molecular Biology, chemistry.chemical_compound, Internal medicine, Cancer genomics, medicine, Clinical endpoint, Humans, Progression-free survival, Melanoma, Multidisciplinary, Molecular medicine, Entinostat, business.industry, Tumor Suppressor Proteins, Iris melanoma, General Chemistry, medicine.disease, Progression-Free Survival, chemistry, Benzamides, business, Ubiquitin Thiolesterase
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4701e25667be28646fe426b3a4d1aefeTest
https://doi.org/10.1038/s41467-021-25332-wTest -
3
المؤلفون: Vasu R. Sah, Mattias F. Lindberg, Henrik Jespersen, Jon Karlsson, Lisa M. Nilsson, Lars Ny, Jonas Nilsson
مصطلحات موضوعية: business.industry, Entinostat, medicine.medical_treatment, Melanoma, Therapeutic effect, Immunotherapy, medicine.disease, Targeted therapy, chemistry.chemical_compound, chemistry, Cancer research, Syngenic, Medicine, Epigenetics, business, Epigenetic therapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::92323fb3c7c3327a6ee99e1c1c732656Test
https://doi.org/10.1101/2021.02.04.429575Test -
4
المؤلفون: Henrik Jespersen, Lisa M. Nilsson, Bengt Andersson, Ulrika Stierner, Ana Carneiro, Lars Ny, Roger Olofsson Bagge, Ingrid Ljuslinder, Hildur Helgadottir, Jonas Nilsson, Gustav J. Ullenhag, Max Levin, Charlotta All-Eriksson
المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)مصطلحات موضوعية: Male, Uveal Neoplasms, 0301 basic medicine, Oncology, Cancer Research, Pyridines, medicine.medical_treatment, Administration, Oral, Phases of clinical research, Pembrolizumab, Study Protocol, chemistry.chemical_compound, Uveal melanoma, 0302 clinical medicine, Histone deacetylase inhibitors, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Medicine, Prospective Studies, Melanoma, Entinostat, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, Benzamides, Metastatic, Epigenetics, Administration, Intravenous, Female, Immunotherapy, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, Genetics, Humans, Cancer och onkologi, business.industry, Programmed cell death 1 receptor, Cancer, medicine.disease, 030104 developmental biology, chemistry, Cancer and Oncology, Concomitant, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bdb7abca1af7c4b4727c229a4d635f7Test
https://doi.org/10.1186/s12885-019-5623-3Test -
5
المؤلفون: Ana Carneiro, Hildur Helgadottir, Charlotta All-Eriksson, Jonas Nilsson, Ulrika Stierner, Bert Andersson, R. Olofsson Bagge, Lisa M. Nilsson, Gustav J. Ullenhag, Lars Ny, Ingrid Ljuslinder, Henrik Jespersen, Malin Levin
المصدر: Annals of Oncology. 30:v907
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Surrogate endpoint, Entinostat, business.industry, Phases of clinical research, Hematology, Pembrolizumab, Clinical trial, 03 medical and health sciences, chemistry.chemical_compound, 030104 developmental biology, 0302 clinical medicine, chemistry, Median follow-up, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Internal medicine, medicine, Clinical endpoint, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::51c78569864ebeee11f2884314cf1288Test
https://doi.org/10.1093/annonc/mdz394.068Test